Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
112,508,491
-
Total 13F shares
-
11,313,743
-
Share change
-
-515,837
-
Total reported value
-
$396,860,238
-
Price per share
-
$35.08
-
Number of holders
-
58
-
Value change
-
-$18,088,356
-
Number of buys
-
30
-
Number of sells
-
13
Institutional Holders of NewAmsterdam Pharma Co N.V. - COMMON STOCK (NAMS) as of Q4 2025
As of 31 Dec 2025,
NewAmsterdam Pharma Co N.V. - COMMON STOCK (NAMS) was held by
58 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,313,743 shares.
The largest 10 holders included
JENNISON ASSOCIATES LLC, Medicxi Ventures Management (Jersey) Ltd, UBS Group AG, TimesSquare Capital Management, LLC, Pictet Asset Management Holding SA, Aberdeen Group plc, Handelsbanken Fonder AB, Atle Fund Management AB, Lisanti Capital Growth, LLC, and VANGUARD GROUP INC.
This page lists
58
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.